{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:14:06Z","timestamp":1789233246364,"version":"build-2803163510"},"reference-count":77,"publisher":"Georg Thieme Verlag KG","issue":"10","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A few decades ago, women diagnosed with multiple sclerosis were discouraged from becoming pregnant. However, with new knowledge about the disease and treatments, this recommendation has changed, and it is pregnancy after the diagnosis of the disease is no longer contraindicated, with family planning being essential in this process. This review aims to provide a comprehensive overview of the family planning process for people with multiple sclerosis.<\/jats:p>","DOI":"10.1055\/s-0044-1791202","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T23:39:47Z","timestamp":1727912387000},"page":"001-011","source":"Crossref","is-referenced-by-count":2,"title":["Patient-centered pregnancy planning in multiple sclerosis: evidence for a new era"],"prefix":"10.1055","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6448-8277","authenticated-orcid":false,"given":"Elisa Matias Vieira de","family":"Melo","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo, Faculdade de Ci\u00eancias M\u00e9dicas, Departamento de Neurologia, S\u00e3o Paulo SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3726-6505","authenticated-orcid":false,"given":"Bruno Cassis Antunes","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo, Faculdade de Ci\u00eancias M\u00e9dicas, Departamento de Neurologia, S\u00e3o Paulo SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-9547","authenticated-orcid":false,"given":"Felipe Teijeiro","family":"Cabral","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo, Faculdade de Ci\u00eancias M\u00e9dicas, Departamento de Neurologia, S\u00e3o Paulo SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1041-6436","authenticated-orcid":false,"given":"Lu\u00edza Alves Monteiro Torre\u00e3o","family":"Villarim","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo, Faculdade de Ci\u00eancias M\u00e9dicas, Departamento de Neurologia, S\u00e3o Paulo SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3983-6019","authenticated-orcid":false,"given":"Maria Fernanda","family":"Mendes","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo, Faculdade de Ci\u00eancias M\u00e9dicas, Departamento de Neurologia, S\u00e3o Paulo SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"H F Harbo","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"issue":"08","key":"ref2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1590\/0004-282","article-title":"Consenso brasileiro para o tratamento da esclerose m\u00faltipla: Academia Brasileira de Neurologia e Comit\u00ea Brasileiro de Tratamento e Pesquisa em Esclerose M\u00faltipla","volume":"76","author":"V D Marques","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"issue":"06","key":"ref3","doi-asserted-by":"publisher","first-page":"e0199446","DOI":"10.1371\/journal.pone.0199446","article-title":"The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil","volume":"13","author":"I Maia Diniz","year":"2018","journal-title":"PLoS One"},{"issue":"03","key":"ref4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.5935\/1518-0557.20210022","article-title":"Multiple sclerosis in pregnancy and its role in female fertility: a systematic review","volume":"25","author":"R Lamaita","year":"2021","journal-title":"JBRA Assist Reprod"},{"issue":"01","key":"ref5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1352458514540843","article-title":"Serum anti-M\u00fcllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis","volume":"21","author":"J Th\u00f6ne","year":"2015","journal-title":"Mult Scler"},{"issue":"04","key":"ref6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"K M Krysko","year":"2023","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105538","DOI":"10.1016\/j.msard.2024.105538","article-title":"What is the importance of family planning in multiple sclerosis? A study in the Brazilian population","volume":"85","author":"E MV Melo","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1035596","DOI":"10.3389\/fneur.2022.1035596","article-title":"Fertility preferences and unmet need for family planning in women with multiple sclerosis","volume":"13","author":"L L\u00f3pez-Reyes","year":"2022","journal-title":"Front Neurol"},{"issue":"22","key":"ref9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1212\/WNL.0b013e3181c3f27d","article-title":"Obstetric outcomes in women with multiple sclerosis and epilepsy","volume":"73","author":"V M Kelly","year":"2009","journal-title":"Neurology"},{"issue":"03","key":"ref10","doi-asserted-by":"publisher","first-page":"e200106","DOI":"10.1212\/NXI.0000000000200106","article-title":"Inflammatory activity after diverse fertility treatments: a multicenter analysis in the modern multiple sclerosis treatment era","volume":"10","author":"E L Graham","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"S 01","key":"ref11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000367640","article-title":"Pregnancy in multiple sclerosis","volume":"72","author":"K Hellwig","year":"2014","journal-title":"Eur Neurol"},{"issue":"02","key":"ref12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40120-023-00439-y","article-title":"Assisted reproductive techniques in multiple sclerosis: recommendations from an expert panel","volume":"12","author":"C Oreja-Guevara","year":"2023","journal-title":"Neurol Ther"},{"issue":"24","key":"ref13","doi-asserted-by":"publisher","first-page":"e2989","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, fingolimod and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis","volume":"96","author":"W Z Yeh","year":"2021","journal-title":"Neurology"},{"issue":"05","key":"ref14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"C Confavreux","year":"1998","journal-title":"N Engl J Med"},{"issue":"01","key":"ref15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1352458518816614","article-title":"Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria","volume":"26","author":"G Bsteh","year":"2020","journal-title":"Mult Scler"},{"issue":"08","key":"ref16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"M P Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"issue":"03","key":"ref17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"G Bandoli","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"05","key":"ref18","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00415-012-6653-9","article-title":"Multiple sclerosis and pregnancy: therapeutic considerations","volume":"260","author":"M K Houtchens","year":"2013","journal-title":"J Neurol"},{"issue":"04","key":"ref19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s13311-017-0562-7","article-title":"Pregnancy: Effect on multiple sclerosis, treatment considerations, and breastfeeding","volume":"14","author":"R Voskuhl","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/07399332.2014.948627","article-title":"Postpartum treatment with immunoglobulin does not prevent relapses of multiple sclerosis in the mother","volume":"36","author":"Y D Fragoso","year":"2015","journal-title":"Health Care Women Int"},{"issue":"06","key":"ref21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1590\/0004-282","article-title":"There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis","volume":"76","author":"G R Rosa","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"issue":"03","key":"ref22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jca.21468","article-title":"Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient","volume":"32","author":"J L Cox","year":"2017","journal-title":"J Clin Apher"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejogrb.2021.02.027","article-title":"Therapeutic plasma exchange in pregnancy: A literature review","volume":"260","author":"M Wind","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"851413","DOI":"10.3389\/fneur.2022.851413","article-title":"Disease-modifying drugs and breastfeeding in multiple sclerosis: a narrative literature review","volume":"13","author":"F Capone","year":"2022","journal-title":"Front Neurol"},{"issue":"10","key":"ref25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/jcm8101623","article-title":"Therapeutic apheresis in acute relapsing multiple sclerosis: current evidence and unmet needs-a systematic review","volume":"8","author":"L Rolfes","year":"2019","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"102682","DOI":"10.1016\/j.msard.2020.102682","article-title":"Pregnancy outcomes in women with Multiple Sclerosis","volume":"48","author":"B Soler","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"04","key":"ref27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1212\/CPJ.0000000000001035","article-title":"Pregnancy-related and perinatal outcomes in women with multiple sclerosis: a nationwide Danish cross-sectional study","volume":"11","author":"J B Andersen","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"01","key":"ref28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.22483","article-title":"Neonatal and delivery outcomes in women with multiple sclerosis","volume":"70","author":"M L van der Kop","year":"2011","journal-title":"Ann Neurol"},{"issue":"06","key":"ref29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/1352458517701314","article-title":"Contraception for women with multiple sclerosis: Guidance for healthcare providers","volume":"23","author":"M K Houtchens","year":"2017","journal-title":"Mult Scler"},{"issue":"06","key":"ref30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/cpdd.377","article-title":"Evaluation of potential drug-drug interaction between delayed-release dimethyl fumarate and a commonly used oral contraceptive (norgestimate\/ethinyl estradiol) in healthy women","volume":"6","author":"B Zhu","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"08","key":"ref31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/13524585231168043","article-title":"ECTRIMS\/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs","volume":"29","author":"S Otero-Romero","year":"2023","journal-title":"Mult Scler"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/13524585221150881","article-title":"Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis","volume":"29","author":"M I Stefanou","year":"2023","journal-title":"Mult Scler"},{"issue":"06","key":"ref33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1097\/AOG.0000000000000541","article-title":"Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review","volume":"124","author":"R Bove","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/medicina56020049","article-title":"Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy's impact on disease activity","volume":"56","author":"G Varyt\u0117","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/brain\/awt356","article-title":"Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden","volume":"137","author":"H Westerlind","year":"2014","journal-title":"Brain"},{"issue":"06","key":"ref36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00281-016-0584-y","article-title":"Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application","volume":"38","author":"S M Gold","year":"2016","journal-title":"Semin Immunopathol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211051012","article-title":"A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis","volume":"14","author":"K Hellwig","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"17","key":"ref38","doi-asserted-by":"publisher","first-page":"e1926","DOI":"10.1212\/WNL.0000000000201029","article-title":"Disease reactivation after cessation of disease-modifying therapy in patients with relapsing-remitting multiple sclerosis","volume":"99","author":"I Roos","year":"2022","journal-title":"Neurology"},{"issue":"01","key":"ref39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","article-title":"Safety of breast feeding during rituximab treatment in multiple sclerosis","volume":"94","author":"B E R\u00f8d","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"102694","DOI":"10.1016\/j.msard.2020.102694","article-title":"Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden","volume":"48","author":"M Korjagina","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"06","key":"ref41","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00415-020-09762-y","article-title":"Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry","volume":"267","author":"K Hellwig","year":"2020","journal-title":"J Neurol"},{"issue":"06","key":"ref42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1352458515623366","article-title":"Glatiramer acetate during early pregnancy: A prospective cohort study","volume":"22","author":"S Herbstritt","year":"2016","journal-title":"Mult Scler"},{"issue":"04","key":"ref43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40264-022-01168-1","article-title":"Pregnancy, fetal, and infant outcomes following maternal exposure to glatiramer acetate during pregnancy and breastfeeding","volume":"45","author":"S Kaplan","year":"2022","journal-title":"Drug Saf"},{"issue":"04","key":"ref44","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1212\/NXI.0000000000000757","article-title":"Safety of potential breast milk exposure to IFN-\u03b2 or glatiramer acetate: One-year infant outcomes","volume":"7","author":"A I Ciplea","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"02","key":"ref45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40120-015-0033-1","article-title":"Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience","volume":"4","author":"R Gold","year":"2015","journal-title":"Neurol Ther"},{"issue":"01","key":"ref46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/ene.15559","article-title":"Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis","volume":"30","author":"J B Andersen","year":"2023","journal-title":"Eur J Neurol"},{"issue":"02","key":"ref47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/13524585231220232","article-title":"Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry","volume":"30","author":"K Hellwig","year":"2024","journal-title":"Mult Scler"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420968414","article-title":"Dimethyl fumarate transfer into human milk","volume":"13","author":"A I Ciplea","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"102147","DOI":"10.1016\/j.msard.2020.102147","article-title":"Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina","volume":"43","author":"N F Liguori","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"07","key":"ref50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1352458519843055","article-title":"Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience","volume":"26","author":"S Vukusic","year":"2020","journal-title":"Mult Scler"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"103529","DOI":"10.1016\/j.msard.2022.103529","article-title":"Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population","volume":"59","author":"J B Andersen","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"6527458","DOI":"10.1155\/2016\/6527458","article-title":"Management of multiple sclerosis in the breastfeeding mother","volume":"2016","author":"S Almas","year":"2016","journal-title":"Mult Scler Int"},{"issue":"05","key":"ref53","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1212\/NXI.0000000000000377","article-title":"Dramatic rebounds of MS during pregnancy following fingolimod withdrawal","volume":"4","author":"G Novi","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"03","key":"ref54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1352458520929628","article-title":"Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study","volume":"27","author":"E Pauliat","year":"2021","journal-title":"Mult Scler"},{"issue":"03","key":"ref55","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/13524585221131486","article-title":"Cladribine and pregnancy in women with multiple sclerosis: The first cohort study","volume":"29","author":"K Dost-Kovalsky","year":"2023","journal-title":"Mult Scler"},{"issue":"02","key":"ref56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/practneurol-2018-002060","article-title":"UK consensus on pregnancy in multiple sclerosis: \u2018Association of British Neurologists\u2019 guidelines","volume":"19","author":"R Dobson","year":"2019","journal-title":"Pract Neurol"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40264-020-00948-x","article-title":"Pregnancy outcomes during the clinical development program of cladribine in multiple sclerosis: An integrated analysis of safety","volume":"43","author":"G Giovannoni","year":"2020","journal-title":"Drug Saf"},{"issue":"05","key":"ref58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1352458520912173","article-title":"Cladribine transfer into human milk: A case report","volume":"27","author":"P Datta","year":"2021","journal-title":"Mult Scler"},{"issue":"10","key":"ref59","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1212\/WNL.0000000000005067","article-title":"Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks","volume":"90","author":"E Portaccio","year":"2018","journal-title":"Neurology"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1352458514546790","article-title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","volume":"21","author":"N Ebrahimi","year":"2015","journal-title":"Mult Scler"},{"issue":"01","key":"ref61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12883-016-0674-4","article-title":"Evaluation of pregnancy outcomes from the Tysabri\u00ae (natalizumab) pregnancy exposure registry: a global, observational, follow-up study","volume":"16","author":"S Friend","year":"2016","journal-title":"BMC Neurol"},{"issue":"05","key":"ref62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"R Kapoor","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"104038","DOI":"10.1016\/j.msard.2022.104038","article-title":"Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30)","volume":"66","author":"G Valero-L\u00f3pez","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"01","key":"ref64","doi-asserted-by":"publisher","first-page":"e2144750","DOI":"10.1001\/jamanetworkopen.2021.44750","article-title":"Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy","volume":"5","author":"K Hellwig","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"07","key":"ref65","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy","volume":"71","author":"A Haghikia","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"715195","DOI":"10.3389\/fimmu.2021.715195","article-title":"Drug and neurofilament levels in serum and breastmilk of women with multiple sclerosis exposed to natalizumab during pregnancy and lactation","volume":"12","author":"U Proschmann","year":"2021","journal-title":"Front Immunol"},{"issue":"04","key":"ref67","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/nu3040442","article-title":"Perspectives on immunoglobulins in colostrum and milk","volume":"3","author":"W L Hurley","year":"2011","journal-title":"Nutrients"},{"issue":"05","key":"ref69","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/ph16050770","article-title":"Monoclonal antibodies in pregnancy and breastfeeding in patients with multiple sclerosis: a review and an updated clinical guide","volume":"16","author":"P Gklinos","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"01","key":"ref70","doi-asserted-by":"publisher","first-page":"e913","DOI":"10.1212\/NXI.0000000000000913","article-title":"Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany","volume":"8","author":"T K\u00fcmpfel","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"ref71","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions","volume":"10","author":"A Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"03","key":"ref72","first-page":"30","article-title":"Anti-CD20 monoclonal antibody therapy after 59 pregnancies in women with neurological conditions: low breastmilk transfer and normal infant development in a multicenter cohort","volume":"28","author":"A Anderson","year":"2022","journal-title":"Mult Scler"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"103963","DOI":"10.1016\/j.msard.2022.103963","article-title":"Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants","volume":"64","author":"R Bove","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.reprotox.2021.12.006","article-title":"Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys","volume":"108","author":"M Bellot","year":"2022","journal-title":"Reprod Toxicol"},{"issue":"04","key":"ref76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00115-024-01621-9","article-title":"Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose","volume":"95","author":"L Witt","year":"2024","journal-title":"Nervenarzt"},{"issue":"11","key":"ref77","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1212\/WNL.0000000000004354","article-title":"Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings","volume":"89","author":"A J Coles","year":"2017","journal-title":"Neurology"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.msard.2020.102146","article-title":"Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years","volume":"43","author":"J Oh","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"01","key":"ref79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40120-022-00421-0","article-title":"Multiple sclerosis in pregnancy: a commentary on disease modification and symptomatic drug therapies","volume":"12","author":"P Iyer","year":"2023","journal-title":"Neurol Ther"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:15:46Z","timestamp":1730808946000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,7,4]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["s00441791202"],"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791202","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}